Characteristics of the studies included in the meta-analysis to investigate the relationship between receiving ESAs and mortality in hemodialysis patients.</p
BackgroundIn recent years, various studies have been conducted to investigate the relationship betwe...
<p>OF, organ failure; PNes, pancreatic necrosis; SAP, severe acute pancreatitis.</p><p>Characteristi...
<p>OS: overall survival; DFS: disease-free survival; PFS: progression-free survival; NR: not reporte...
Flowchart of selected studies for meta-analysis to investigate the relationship between receiving ES...
Evaluation of publication bias in meta-analysis studies of the relationship between receiving ESAs a...
Adjusted variables to investigate the relationship between receiving ESAs and the mortality of hemod...
Subgroup analysis in the relationship b between receiving ESAs and the mortality of hemodialysis pat...
Sensitivity analysis of the relationship between receiving ESAs and the mortality of hemodialysis pa...
Relationship between receiving ESAs and the mortality of hemodialysis patients.</p
BackgroundIn recent years, various studies have been conducted to investigate the relationship betwe...
<p>Values are presented as mean (standard deviation) or percentage.</p><p>Abbreviations: ESA = Eryth...
<p>Data are reported as mean ± standard deviation unless otherwise indicated.</p><p>ESRD, end stage ...
Data Availability statement: All relevant data (Search strategy; quality assessment; prevalence of ...
Background: Previous meta-analyses suggest that treatment with erythropoiesis-stimulating agents (ES...
<p>Clinical characteristics of the studies included in the meta-analysis (n = 9).</p
BackgroundIn recent years, various studies have been conducted to investigate the relationship betwe...
<p>OF, organ failure; PNes, pancreatic necrosis; SAP, severe acute pancreatitis.</p><p>Characteristi...
<p>OS: overall survival; DFS: disease-free survival; PFS: progression-free survival; NR: not reporte...
Flowchart of selected studies for meta-analysis to investigate the relationship between receiving ES...
Evaluation of publication bias in meta-analysis studies of the relationship between receiving ESAs a...
Adjusted variables to investigate the relationship between receiving ESAs and the mortality of hemod...
Subgroup analysis in the relationship b between receiving ESAs and the mortality of hemodialysis pat...
Sensitivity analysis of the relationship between receiving ESAs and the mortality of hemodialysis pa...
Relationship between receiving ESAs and the mortality of hemodialysis patients.</p
BackgroundIn recent years, various studies have been conducted to investigate the relationship betwe...
<p>Values are presented as mean (standard deviation) or percentage.</p><p>Abbreviations: ESA = Eryth...
<p>Data are reported as mean ± standard deviation unless otherwise indicated.</p><p>ESRD, end stage ...
Data Availability statement: All relevant data (Search strategy; quality assessment; prevalence of ...
Background: Previous meta-analyses suggest that treatment with erythropoiesis-stimulating agents (ES...
<p>Clinical characteristics of the studies included in the meta-analysis (n = 9).</p
BackgroundIn recent years, various studies have been conducted to investigate the relationship betwe...
<p>OF, organ failure; PNes, pancreatic necrosis; SAP, severe acute pancreatitis.</p><p>Characteristi...
<p>OS: overall survival; DFS: disease-free survival; PFS: progression-free survival; NR: not reporte...
DOI
Add to ORKG